

Advancing Healthcare: A Venture Capital Firm’s Commitment to Medical Technologies
In the fast-paced landscape of healthcare innovation, our venture capital firm, Metti RnD, stands as a driving force dedicated to propelling visionary startups in the field of medical technologies. Specializing in investments within the healthcare sector, Metti RnD is committed to advancing transformative solutions that redefine patient care, improve diagnostics, and pioneer the future of medical innovation.
Introduction: Metti RnD was founded on the belief that cutting-edge medical technologies have the power to revolutionize healthcare delivery. Our mission is to identify, support, and nurture startups that demonstrate exceptional promise in advancing medical technologies, from diagnostics and telemedicine to innovative medical devices.
Investment Focus:
-
Digital Health Solutions: Metti RnD actively seeks startups at the forefront of digital health. Investments target companies developing solutions that leverage technology to enhance patient engagement, remote monitoring, and overall healthcare delivery.
-
Medical Devices and Equipment: Recognizing the importance of innovation in medical devices, Metti RnD invests in startups developing advanced medical devices. This includes diagnostic equipment, wearable devices, and technologies that improve patient outcomes and treatment efficacy.
-
Telemedicine and Remote Healthcare: Metti RnD supports startups specializing in telemedicine solutions. Investments aim to advance remote healthcare capabilities, including virtual consultations, remote patient monitoring, and telehealth platforms.
-
Biotechnology and Life Sciences: Understanding the transformative potential in biotechnology, Metti RnD invests in startups developing breakthrough solutions in genomics, personalized medicine, and life sciences that contribute to advancements in diagnostics and treatment.
Investment Process: Metti RnD employs a meticulous investment process designed to identify startups with high potential for impact in medical technologies. This includes comprehensive market analysis, technical due diligence, and an evaluation of a company’s scientific expertise, leadership, and scalability. Our team of experts, with a deep understanding of both venture capital and healthcare, ensures that each investment aligns with our mission to drive innovation in the medical sector.
Portfolio Companies: While specific details of our portfolio are confidential, Metti RnD strategically invests in startups that demonstrate a commitment to pushing the frontiers of medical technologies. Our portfolio reflects a diverse range of innovations contributing to the advancement of healthcare delivery.
Cross-Disciplinary Collaboration: Beyond traditional applications, Metti RnD recognizes the importance of cross-disciplinary collaboration. We actively seek startups addressing challenges and unlocking opportunities at the intersection of technology and healthcare.
Ethical Considerations: Metti RnD places a significant emphasis on ethical considerations in medical technology development. We support startups that prioritize patient safety, data security, and ethical use of medical technologies in various applications.
Conclusion: As medical technologies continue to redefine patient care and healthcare delivery, Metti RnD remains dedicated to being at the forefront of this revolution. Through strategic investments, industry expertise, and a commitment to ethical and innovative healthcare solutions, Metti RnD aims to be a driving force for transformative changes in the field of medical technologies. Together with our portfolio companies, we are advancing healthcare and shaping the future of medical innovation.
Introduction: Metti RnD was founded on the belief that robotics technologies hold the key to transforming industries and enhancing human capabilities. Our mission is to identify, support, and nurture startups that demonstrate exceptional promise in advancing robotics technologies, from autonomous systems to collaborative robots (cobots).
Investment Focus:
-
Autonomous Systems and Vehicles: Metti RnD actively seeks startups at the forefront of autonomous technologies. Investments target companies developing autonomous vehicles, drones, and robotic systems that can navigate and interact with the environment independently.
-
Collaborative Robots (Cobots): Recognizing the importance of human-robot collaboration, Metti RnD invests in startups developing collaborative robots. Investments aim to enhance automation in various industries, fostering seamless interaction between robots and human workers.
-
Industrial Robotics: Metti RnD supports startups specializing in industrial robotics solutions. Investments target companies developing robotic arms, automation systems, and robotics technologies that optimize manufacturing processes, logistics, and supply chain operations.
-
Healthcare Robotics: Understanding the transformative potential in healthcare, Metti RnD invests in startups developing robotics solutions for medical applications. This includes robotic-assisted surgery, rehabilitation robotics, and assistive devices for healthcare settings.
Investment Process: Metti RnD employs a meticulous investment process designed to identify startups with high potential for impact in robotics. This includes comprehensive market analysis, technical due diligence, and an evaluation of a company’s technological prowess, leadership, and scalability. Our team of experts, with a deep understanding of both venture capital and robotics, ensures that each investment aligns with our mission to drive innovation in the robotics sector.
Portfolio Companies: While specific details of our portfolio are confidential, Metti RnD strategically invests in startups that demonstrate a commitment to pushing the frontiers of robotics technologies. Our portfolio reflects a diverse range of innovations contributing to the advancement of automation and robotics across industries.
Cross-Industry Applications: Beyond traditional applications, Metti RnD recognizes the cross-industry potential of robotics technologies. We actively seek startups addressing challenges and unlocking opportunities in fields such as agriculture, logistics, construction, and more.
Ethical and Safety Considerations: Metti RnD places a significant emphasis on ethical considerations in robotics development. We support startups that prioritize safety, transparency, and ethical use of robotics technologies in various applications.
Conclusion: As robotics technologies continue to redefine automation and industry landscapes, Metti RnD remains dedicated to being at the forefront of this revolution. Through strategic investments, industry expertise, and a commitment to ethical and innovative robotics development, Metti RnD aims to be a driving force for transformative changes in the field of robotics technologies. Together with our portfolio companies, we are innovating tomorrow and shaping the future of robotics.
- Rat/Mouse PINP EIA
- IDS-iSYS PTH (1-34)
- Corticosterone EIA
- Corticosterone HS
- Urine CartiLaps EIA
- Rat/Mouse PINP EIA
- IDS-iSYS PTH (1-34)
- Corticosterone EIA
- Corticosterone HS
- Urine CartiLaps EIA
OUR RESEARCH
The master-builders off human happiness no one rejects, ours avoids pleasure itself, because seds is pleasure, but because those who do not know to rationally.
The master-builders off human happiness no one rejects, ours avoids pleasure itself, because seds is pleasure, but because those who do not know to rationally.
The master-builders off human happiness no one rejects, ours avoids pleasure itself, because seds is pleasure, but because those who do not know to rationally.
Contact us for help?
Contact with us through our representative or submit a business inquiry online.